Lloyd George W.
Insider CIK 1814899 · RPRX EVP, Investments & GC
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2025-12-18 | 2025-12-19 | 30,654 | $38.50 | $1.18M | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-17 | 2025-12-19 | 79,346 | $38.57 | $3.06M | 30,654 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-03 | 2025-12-05 | 110,000 | $39.77 | $4.37M | 110,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 2,770 | $38.29 | $106.1K | 230 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 2,470 | $39.01 | $96.4K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 25,530 | $38.28 | $977.3K | 2,470 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 47,401 | $38.28 | $1.81M | 4,599 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 4,628 | $39.01 | $180.5K | 6,084 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 47,798 | $38.28 | $1.83M | 10,712 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 230 | $39.03 | $9.0K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-11-19 | 2025-11-21 | 4,599 | $39.01 | $179.4K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-11-05 | 2025-11-07 | 6,168 | — | $0 | 58,510 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2025-08-08 | 2025-08-08 | 8,500 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-08-06 | 2025-08-08 | 3,696 | — | $0 | 52,342 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2025-05-16 | 2025-05-20 | 1,944,471 | — | $0 | 1,944,471 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-08 | 2025-05-09 | 48,646 | — | $0 | 48,646 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2024-08-12 | 2024-08-12 | 7,920 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2023-11-13 | 2023-11-14 | 5,000 | — | $0 | 245,299 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2023-11-13 | 2023-11-14 | 10,000 | — | $0 | 162,680 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2023-11-13 | 2023-11-14 | 50,000 | — | $0 | 80,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2023-11-13 | 2023-11-14 | 100,000 | — | $0 | 220,000 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2023-08-08 | 2023-08-08 | 5,555 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-06-06 | 2023-06-06 | 79,099 | $33.82 | $2.68M | 30,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-06-05 | 2023-06-06 | 19,215 | $33.54 | $644.5K | 109,099 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-06-02 | 2023-06-06 | 1,686 | $33.54 | $56.5K | 128,314 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-06-02 | 2023-06-06 | 92,221 | $33.65 | $3.10M | 120,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-03-29 | 2023-03-30 | 12,779 | $37.03 | $473.2K | 212,221 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-03-28 | 2023-03-30 | 100,000 | $37.06 | $3.71M | 225,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-02-23 | 2023-02-27 | 25,000 | $37.27 | $931.8K | 325,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-22 | 2022-11-22 | 14,469 | $43.19 | $624.9K | 130,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-22 | 2022-11-22 | 1,900 | $43.14 | $82.0K | 350,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-21 | 2022-11-22 | 3,100 | $43.11 | $133.6K | 351,900 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-21 | 2022-11-22 | 20,531 | $43.11 | $885.1K | 144,469 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-10 | 2022-11-14 | 25,000 | $43.85 | $1.10M | 355,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-11-10 | 2022-11-14 | 25,000 | $43.85 | $1.10M | 165,000 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2022-08-12 | 2022-11-14 | 5,889 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-08-10 | 2022-08-11 | 8,995 | $43.93 | $395.2K | 201,114 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-08-09 | 2022-08-11 | 11,859 | $43.92 | $520.8K | 210,109 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-28 | 2022-08-01 | 4,046 | $43.97 | $177.9K | 221,968 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-27 | 2022-07-27 | 25,000 | $43.76 | $1.09M | 380,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-27 | 2022-07-27 | 100 | $43.90 | $4.4K | 226,014 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-26 | 2022-07-27 | 5,443 | $43.03 | $234.2K | 405,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-26 | 2022-07-27 | 13,886 | $43.12 | $598.8K | 226,114 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-25 | 2022-07-27 | 11,114 | $42.98 | $477.7K | 228,886 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-25 | 2022-07-27 | 19,557 | $42.90 | $839.0K | 410,443 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-27 | 2022-05-31 | 13,974 | $40.77 | $569.7K | 430,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-26 | 2022-05-31 | 86,026 | $40.21 | $3.46M | 443,974 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-23 | 2022-05-25 | 100,000 | $40.27 | $4.03M | 530,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-11-17 | 2021-11-18 | 84,148 | $42.39 | $3.57M | 630,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-11-16 | 2021-11-18 | 27,341 | $43.19 | $1.18M | 495,860 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-11-16 | 2021-11-18 | 65,852 | $42.12 | $2.77M | 714,148 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-11-16 | 2021-11-18 | 72,659 | $42.33 | $3.08M | 523,201 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2021-09-10 | 2021-11-18 | 1,282 | — | $0 | 5,889 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-26 | 2021-07-27 | 4,913 | $39.81 | $195.6K | 595,860 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-26 | 2021-07-27 | 8,449 | $39.76 | $335.9K | 780,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-13 | 2021-07-14 | 5,068 | $42.01 | $212.9K | 600,773 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-13 | 2021-07-14 | 17,981 | $42.01 | $755.4K | 788,449 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-12 | 2021-07-14 | 100 | $42.04 | $4.2K | 806,430 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-08 | 2021-07-08 | 40,667 | $42.05 | $1.71M | 806,530 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-08 | 2021-07-08 | 8,392 | $42.05 | $352.9K | 605,841 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-07 | 2021-07-08 | 400 | $42.02 | $16.8K | 614,233 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-07 | 2021-07-08 | 2,500 | $42.01 | $105.0K | 847,197 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-06 | 2021-07-08 | 30,303 | $42.41 | $1.29M | 849,697 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-07-06 | 2021-07-08 | 6,227 | $42.42 | $264.1K | 614,633 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-10 | 2021-06-14 | 40,000 | $46.52 | $1.86M | 880,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-10 | 2021-06-14 | 10,000 | $46.45 | $464.5K | 240,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-10 | 2021-06-14 | 20,000 | $46.46 | $929.2K | 620,860 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-08 | 2021-06-08 | 10,000 | $46.47 | $464.7K | 250,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-08 | 2021-06-08 | 20,000 | $46.48 | $929.6K | 640,860 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-08 | 2021-06-08 | 40,000 | $46.48 | $1.86M | 920,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 15,147 | $45.89 | $695.1K | 264,853 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 36,619 | $46.74 | $1.71M | 960,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 33,381 | $46.10 | $1.54M | 996,619 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 13,400 | $46.77 | $626.7K | 660,860 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 19,100 | $45.97 | $878.0K | 674,260 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 4,853 | $46.54 | $225.9K | 260,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-04 | 2021-06-08 | 20,000 | $44.81 | $896.2K | 280,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-04 | 2021-06-08 | 20,000 | $44.69 | $893.8K | 693,360 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-04 | 2021-06-08 | 20,000 | $44.85 | $897.0K | 1,030,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-02 | 2021-06-04 | 12,500 | $42.09 | $526.1K | 713,360 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-02 | 2021-06-04 | 50,000 | $42.13 | $2.11M | 1,050,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 67,586 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 90,000 | — | $0 | 172,680 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 30,000 | — | $0 | 264,027 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 900,000 | — | $0 | 1,100,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 675,860 | — | $0 | 725,860 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-14 | 2021-04-16 | 13,924 | $42.12 | $586.5K | 50,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-14 | 2021-04-16 | 55,898 | $42.14 | $2.36M | 200,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-12 | 2021-04-14 | 360 | $42.32 | $15.2K | 255,898 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-04-12 | 2021-04-14 | 89 | $42.32 | $3.8K | 63,924 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-22 | 2021-03-24 | 43,642 | $46.32 | $2.02M | 256,358 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-22 | 2021-03-24 | 10,987 | $46.34 | $509.1K | 64,013 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-22 | 2021-03-24 | 100 | $47.04 | $4.7K | 256,258 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 3,510 | $47.85 | $168.0K | 300,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 22,375 | $46.89 | $1.05M | 77,625 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 2,625 | $47.84 | $125.6K | 75,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-03-02 | 2021-03-04 | 96,490 | $46.89 | $4.52M | 303,510 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 40,000 | — | $0 | 556,707 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-12-31 | 2021-01-05 | 10,000 | — | $0 | 73,638 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-12-31 | 2021-01-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 26,276 | — | $0 | 2,050 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-22 | 3,000 | $28.00 | $84.0K | 3,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 262,760 | — | $0 | 273,960 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-22 | 11,200 | $28.00 | $313.6K | 11,200 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 7,730 | — | $0 | 7,730 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 83,638 | — | $0 | 83,638 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 596,707 | — | $0 | 596,707 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 28,326 | — | $0 | 28,326 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 353,000 | — | $0 | 353,000 | SEC↗ |